Market revenue in 2023 | USD 41.2 million |
Market revenue in 2030 | USD 67.7 million |
Growth rate | 7.4% (CAGR from 2023 to 2030) |
Largest segment | Functional genomics |
Fastest growing segment | Pathway Analysis |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Functional Genomics, Epigenomics, Pathway Analysis, Biomarker Discovery |
Key market players worldwide | Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Eppendorf, Eurofins Scientific SE, Roche Holding AG ADR, GE Aerospace, Illumina Inc, Myriad Genetics Inc, Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc, Qiagen NV, Quest Diagnostics Inc, Thermo Fisher Scientific Inc, 23andMe Holding Co Class A |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to genomics market will help companies and investors design strategic landscapes.
Functional genomics was the largest segment with a revenue share of 32.28% in 2023. Horizon Databook has segmented the UAE genomics market based on functional genomics, epigenomics, pathway analysis, biomarker discovery covering the revenue growth of each sub-segment from 2018 to 2030.
Key companies in the market are undertaking various strategic initiatives to strengthen their market position. In April 2022, Viafet Genomics Laboratory collaborated with Euformatics to provide carrier screening and clinical diagnostics in the UAE. Similarly, in November 2022, the Illumina Solutions Center in Dubai offered its services to scientists, medical professionals, and officials from the Emirate.
To enhance and provide precision medicine to patients at scale, the new cutting-edge laboratory will increase genomics capabilities and develop local knowledge in the field. Illumina's most recent NGS and array technologies are situated in the over 9,100 square-foot solutions center.
Numerous clinical applications, including oncology, genetic disease testing, noninvasive prenatal testing, and quick diagnostic testing, can be performed with the equipment.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE genomics market , including forecasts for subscribers. This country databook contains high-level insights into UAE genomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account